Veradermics (MANE) Director Suvretta Capital Receives Stock Awards

What Happened

• Suvretta Capital Management, LLC (reported as a Director) was granted two derivative awards on May 1, 2026: 149,000 shares and 151,000 shares, each with an exercise/acquisition price of $100.00 per share. The reported cash-equivalent values are $14,899,985 and $15,099,985, for a combined value of $29,999,970 (300,000 shares). The filing classifies these as "A" (grant/award/other acquisition), i.e., an acquisition via award of derivative securities. See Exhibit 99.1 for the issuer’s explanation of the awards.

Key Details

• Transaction date: 2026-05-01
• Filing date: 2026-05-05 (Form 4 filed within the required reporting window)
• Awards: 149,000 shares @ $100.00 and 151,000 shares @ $100.00
• Reported value: $14,899,985 and $15,099,985 (total $29,999,970)
• Security type: Derivative awards (per Form 4); exhibit 99.1 contains explanatory notes (footnotes F1–F6)
• Shares owned after transaction: Not specified in the provided filing summary (check Exhibit 99.1 or the full Form 4 for holdings)
• Exhibits included: 99.1 (Explanation), 99.2 (Joint Filer Info), 99.3 (Signatures)

Context

• This was a grant/award (an acquisition of derivative securities), not an open-market purchase or sale. Derivative awards can be options, RSUs, or similar instruments; the filing references Exhibit 99.1 for the precise nature and terms. Because this is an award to an entity reported as a director, it does not necessarily reflect a direct open-market purchase by an individual insider. The Form 4 was filed on May 5, 2026, which is within the typical two-business-day deadline for reporting these transactions.